Ernexa Therapeutics Inc. Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent
Ernexa Therapeutics Inc. (ERNA) reported Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent of 21.00% for the 0-month period ending 2017-12-22, per its 10-K filed 2018-03-09.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate · last filed 2018-03-09
- 2017-12-22: Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent 0 month 21.00%.
| Period end | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent 0 month |
|---|---|
| 2017-12-22 | 21.00% 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |